1 / 1

Immune Thrombocytopenia Market

The market size of Immune Thrombocytopenia in 7MM was USD 2527.72 Million in 2017. <br><br>The total prevalent population of Immune Thrombocytopenia in the 7MM is estimated to be approximately 184,676 in 2020.<br><br>The key players in the Immune Thrombocytopenia market include Octapharma USA, Amgen, CSL Behring, Dova Pharmaceuticals, Rigel Pharmaceuticals, Novartis, Bio Products Laboratory, Takeda, AstraZeneca, Biotest, SK Plasma, Argenx, Kezar Life Sciences, UCB Biopharma, Bristol-Myers Squibb, Principia Biopharma, Protalex and others.<br><br>For more detailed information visit: <br>https://www.delveinsight.com/report-store/immune-thrombocytopenia-market<br><br>

DelveInsight
Télécharger la présentation

Immune Thrombocytopenia Market

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    More Related